FDA's off-label guidance harsh, but better than nothing, say legal experts
Sales reps could be effectively barred from circulating journal article reprints discussing off-label uses under FDA's draft guidance on "good reprint practices," and the agency considers the policy to be effective already, even in its draft form.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.